Henry "Mark" Dunnenberger, PharmD

Bringing Genomics to the Front Lines of Care: The NorthShore Experience


Thursday, October 3, 2019 | 2:00 to 3:00 p.m. | 2-650 Moos Tower (TC)
(Note special time and location)

Dr. Dunnenberger is Director of Pharmacogenomics in the Center for Molecular Medicine at NorthShore University HealthSystem (NorthShore), and leads the various clinical pharmacogenomics implementation projects within the Center for Personalized Medicine. The goal of these projects is to improve the care and health outcomes of NorthShore University HealthSystem patients through pharmacogenomics-based strategies. He joined NorthShore in 2014. Dr. Dunnenberger leads the Pharmacogenomics Clinic, which serves as part of a system-wide initiative building upon the health system’s strong foundation in genetics and molecular medicine. The Clinic is among only a few across the country, and the first of its kind in the Chicagoland area that pre-emptively screens patients for responses to medications based on genetic makeup. His clinical expertise and research interests include translating pharmacogenomics into clinical practice, developing information technology solutions for delivering genetic information to both clinicians and patients in a practical manner, and evaluating methods for educating healthcare professionals about pharmacogenetics Dr. Dunnenberger has co-authored sixteen original publications, including several CPIC guidelines. He earned his PharmD from the University of Tennessee Health Science Center College of Pharmacy in 2012. He completed a PGY1 Pharmacy Practice Residency at Mission Hospital in Asheville, North Carolina, and a PGY2 Clinical Pharmacogenetics Residency in the Department of Pharmaceutical Sciences at St. Jude Children’s Research Hospital in Memphis, Tennessee.


Joint Accreditation LogoContinuing Education Credit

In support of improving patient care, University of Minnesota Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 


American Nurses Credentialing Center (ANCC) — This activity is awarded up to 1 ANCC contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

American Medical Association (AMA) — The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council for Pharmacy Education — The Universal Activity Number is JA0000810-0000-20-029-H04-P. This knowledge-based activity has been approved for 1 contact hour.

Other Health Professionals — It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or re-certification for their discipline.